Managed Healthcare Executive March 14, 2024
The new collaboration gives Prime access to Capital Rx’s claims system; Prime has become a minority investor in Capital Rx.
Prime Therapeutics will now have access to Capital Rx’s technology platform through a new alliance between the two PBMs. As part of the strategic alliance, Prime has become a minority investor in Capital Rx.
Capital Rx’s technology, JUDI, unifies pharmacy benefit management operations — from underwriting, implementation, claim adjudication, data integration, prior authorization, patient communication, client reporting, invoicing, and reimbursement.
Prime executives said the collaboration will augment Prime’s scale, financial management, clinical expertise and allow for data and systems that can be connected and integrated more efficiently. This alliance with Capital Rx enables Prime to enhance core capabilities and ensure...